Gene · 7516
Papers1,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 1,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analysis of Epigenetic Alterations in Homologous Recombination DNA Repair Genes in Male Breast Cancer. | Int J Mol Sci | 2020 | 32295201 | PubTator, text mining | PubMed |
| Spectrum of germline cancer susceptibility gene mutations in Turkish colorectal cancer patients: a single center study | Turk J Med Sci | 2020 | 32283892 | PubTator, text mining | PubMed |
| ERCC2 Lys751Gln rs13181 and XRCC2 Arg188His rs3218536 Gene Polymorphisms Contribute to Subsceptibility of Colon, Gastric, HCC, Lung And Prostate Cancer. | J BUON | 2020 | 32277685 | PubTator, text mining | PubMed |
| Evaluation of X-Ray Repair Cross-Complementing Family Members as Potential Biomarkers for Predicting Progression and Prognosis in Hepatocellular Carcinoma. | Biomed Res Int | 2020 | 32258128 | PubTator, text mining | PubMed |
| RAD51Bme Levels as a Potential Predictive Biomarker for PD-1 Blockade Response in Non-Small Cell Lung Cancer. | J Clin Med | 2020 | 32252414 | PubTator, text mining | PubMed |
| Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes. | Nat Commun | 2020 | 32242007 | PubTator, text mining | PubMed |
| Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients. | Cancers (Basel) | 2020 | 32235514 | PubTator, text mining | PubMed |
| Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. | Food Chem Toxicol | 2020 | 32234424 | PubTator, text mining | PubMed |
| Pulsed low dose-rate irradiation response in isogenic HNSCC cell lines with different radiosensitivity. | Radiol Oncol | 2020 | 32229678 | PubTator, text mining | PubMed |
| Association of XRCC1, XRCC2 and XRCC3 Gene Polymorphism with Esophageal Cancer Risk. | Clin Exp Gastroenterol | 2020 | 32214837 | PubTator, text mining | PubMed |
| Evaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma. | Turk Gogus Kalp Damar Cerrahisi Derg | 2020 | 32175161 | PubTator, text mining | PubMed |
| The Rational Design and Biological Mechanisms of Nanoradiosensitizers. | Nanomaterials (Basel) | 2020 | 32168899 | PubTator, text mining | PubMed |
| Identification of Three lncRNAs as Potential Predictive Biomarkers of Lung Adenocarcinoma. | Biomed Res Int | 2020 | 32149133 | PubTator, text mining | PubMed |
| Interplay between DNA damage repair and apoptosis shapes cancer evolution through aneuploidy and microsatellite instability. | Nat Commun | 2020 | 32144251 | PubTator, text mining | PubMed |
| Aberrant Expression of RAD52, Its Prognostic Impact in Rectal Cancer and Association with Poor Survival of Patients. | Int J Mol Sci | 2020 | 32143539 | PubTator, text mining | PubMed |
| Update Breast Cancer 2020 Part 1 - Early Breast Cancer: Consolidation of Knowledge About Known Therapies. | Geburtshilfe Frauenheilkd | 2020 | 32139917 | PubTator, text mining | PubMed |
| From single gene analysis to single cell profiling: a new era for precision medicine. | J Exp Clin Cancer Res | 2020 | 32138788 | PubTator, text mining | PubMed |
| Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations. | Pract Lab Med | 2020 | 32123717 | PubTator, text mining | PubMed |
| The Development of Rucaparib/Rubraca®: A Story of the Synergy Between Science and Serendipity. | Cancers (Basel) | 2020 | 32121331 | PubTator, text mining | PubMed |
| Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells. | Front Endocrinol (Lausanne) | 2020 | 32117061 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7516/papers?page=37